Safety of jakinibs: lessons from ORAL Surveillance

Rheumatology (Oxford). 2022 Nov 2;61(11):4223-4225. doi: 10.1093/rheumatology/keac166.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Janus Kinase Inhibitors*
  • Janus Kinases

Substances

  • Janus Kinase Inhibitors
  • Janus Kinases